Bipolar Disorder Test vs Genesis Study

Bipolar Disorder is a mental disorder that causes shifts in a person's mood, energy, and thoughts. People with bipolar disorder experience high and low moods (mania and depression, respectively) that are more extreme than what people typically experience. This can lead to a lot of stress and problems with family, work, money, and the law. This app contains a self-report questionnaire to help screen for symptoms related to bipolar disorder. It also contains information to help you get a better understanding of this mental illness. Bipolar Disorder Test is designed to evaluate your symptoms of bipolar disorder with a scientifically-supported 15-question test. It uses the Mood Disorder Questionnaire (MDQ), a screening questionnaire for bipolar spectrum disorder that is commonly used in research and healthcare settings. Bipolar Test contains four tools: - Start Test: take the MDQ questionnaire to screen for bipolar disorder - Result: understand your test results and get resources tailored to your result - Information: learn about bipolar spectrum disorder and discover additional resources that can help you on your path to recovery Disclaimer: The MDQ is NOT a diagnostic test. A diagnosis can only be provided by a qualified healthcare professional. Please consult a physician or mental health professional if you are concerned about bipolar disorder.  References: Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck Jr, P. E., ... & Russell, J. M. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. American Journal of Psychiatry, 157(11), 1873-1875.

A 12-month randomised, double-blind, controlled, international multicentre trial comparing changes in cigarette consumption after switching to high or low nicotine strength e-cigarettes in smokers with Schizophrenia spectrum disorders. This will be a multicenter, 12-months prospective trial, utilizing a randomized, double-blind, 2-arm parallel, switching design to compare effectiveness, tolerability, acceptability, and pattern of use between high (JUUL 5% nicotine) and low nicotine strength devices (JUUL 1.5% nicotine) in adult smokers with schizophrenia spectrum disorders. The study will take place at 5 sites: 1 in the UK (London) and possibly 4 in Italy. DISCLAIMER : To seek a doctor’s advice in addition to using this app and before making any medical decisions. We are using HealthKit to get step count to display on Health Dairy screen and graph on Report screen. We also send daily step count to server with questionary for study purpose.